How malaria parasites exploit mechanism for escaping elimination could provide novel strategies targeting chronic malaria ...

In addition to complementing AAV manufacturing, the company’s Plasmid DNA (pDNA) platform is now available as a standalone service.

Scientists say study findings indicate that TC IV cells may represent a therapeutic target for the treatment of ...

Researchers were able to test how viruses replicate differently across various bat species and organs using the new organoid ...

To address this challenge, CTMC has established a patient material bank, enabling early-stage process development with clinically relevant samples. This resource also supports continuous process ...

Estrogen-related receptors (ERRs) regulate muscle mitochondria in mice, revealing a new potential drug targets for metabolic ...

CEO Serge Saxonov, PhD, acknowledged that its R&D operation “definitely ended up being impacted in a substantial way” while ...

Treated with an individualized gene-editing therapy that corrects mutations directly on the genome, a patient shows ...

Imprint has raised $15 million to decode the body's immune memory for understanding chronic diseases, such as long-COVID and ...

Forge says it will provide Fractyl process development, cGMP manufacturing, and analytical development services.

Study in mice shows how a host-elicited factor benefits gut immunological homeostasis by selectively targeting commensal ceramide molecules.

Not designing with manufacturing in mind—even during early development—is a key reason fledgling biopharma companies fail.